Thermo Fisher Raised Full-Year Guidance After a Standout Q2 Earnings Call
Thermo Fisher Scientific (TMO) reported strong Q2 2026 earnings, exceeding its own guidance with revenue of $11.99 billion and adjusted EPS of $6.03. This performance was largely driven by a recovery in the pharma and biotech sectors, leading management to raise full-year revenue guidance …
Sharemaestro market context Trend signal active 52 weeks +39.2% · Next-week setup positive 55.1%